Zobrazeno 1 - 10
of 3 368
pro vyhledávání: '"hepatitis c virus (hcv)"'
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 40, Iss 11, Pp 962-971 (2024)
Abstract Universal neonatal hepatitis B virus (HBV) vaccination and the advent of direct‐acting antivirals (DAA) against hepatitis C virus (HCV) have reshaped the epidemiology of chronic liver diseases. However, some aspects of the management of ch
Externí odkaz:
https://doaj.org/article/d27f7333d42a4c2fbc4ecc66fdfcce63
Autor:
Mathew Folaranmi Olaniyan, Kemi Felicia Ajiboye, Ogbeche Richard Ochagu, Tolulope Busayo Olaniyan, Taiwo Medinat Adeniran, Adelani Wakili Tijani, Phoebe Nwamaka Kanikwu, Obataze Josephine Apoyovwere, Odekunle Bola Odegbemi
Publikováno v:
Journal of Current Oncology and Medical Sciences, Vol 4, Iss 3, Pp 896-906 (2024)
Introduction: Hepatitis B virus (HBV) infection is a significant health challenge globally, especially in sub-Saharan Africa. Co-infections with HIV and HCV worsen HBV-related liver diseases, complicating clinical management. Alpha-fetoprotein (AFP)
Externí odkaz:
https://doaj.org/article/fcdde78594c64f0d8edf349686aec514
Autor:
Takeshi Chida, Kazuyoshi Ohta, Hidenao Noritake, Masahiro Matsushita, Gou Murohisa, Fujito Kageyama, Yuzo Sasada, Tatsuki Oyaizu, Minoru Tsugiki, Katsutoshi Tamakoshi, Takeyuki Nakajima, Takafumi Suda, Kazuhito Kawata
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Lysyl oxidase-like 2 (LOXL2) mediates the crosslinking of extracellular collagen, reflecting qualitative changes in liver fibrosis. This study aimed to validate the utility of serum LOXL2 levels as a predictive biomarker for the development
Externí odkaz:
https://doaj.org/article/2bce7fd31c9a4d30a37a2d1e98ff83b9
Publikováno v:
Journal of Biological Dynamics, Vol 18, Iss 1 (2024)
In a recent study, a mathematically identical ODE model is derived from a multiscale PDE model of hepatitis C virus infection, which helps to overcome the limitations of the PDE model in the analysis. Here, an extended proposed model is formulated fo
Externí odkaz:
https://doaj.org/article/7c8e04621bcc4914b976db093c6d06eb
Autor:
Mohamed Elbadry, Mahmoud Badawi, Naglaa Youssef, Martin Duracinsky, Shereen A. Saleh, Anna Funk, Hagar Elessawy, Eva Rumpler, Khadiga Sayed, Anca Vasiliu, Yoann Madec, Arnaud Fontanet, Mohamed El-Kassas
Publikováno v:
Egyptian Liver Journal, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract Background Chronic hepatitis C virus (HCV) infection negatively impacts health-related quality of life (HRQL). We aimed to assess patient-reported outcomes (PROs) to evaluate the impact of treating chronic HCV with directly acting antivirals
Externí odkaz:
https://doaj.org/article/694fde0c1c3c4f92a91bd2e8f8ad76af
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background To investigate the trends in health-related quality of life (HRQoL) among hepatitis C virus (HCV) patients and to assess the longitudinal impact of antiviral therapy on their well-being. Methods In this prospective multicenter obs
Externí odkaz:
https://doaj.org/article/ac6451c3d0c1414aa141f16899c06b1f
Autor:
Vicky Caponigro, Anna L. Tornesello, Fabrizio Merciai, Danila La Gioia, Emanuela Salviati, Manuela G. Basilicata, Simona Musella, Francesco Izzo, Angelo S. Megna, Luigi Buonaguro, Eduardo Sommella, Franco M. Buonaguro, Maria L. Tornesello, Pietro Campiglia
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-15 (2023)
Abstract Background Early diagnosis of hepatocellular carcinoma (HCC) is essential towards the improvement of prognosis and patient survival. Circulating markers such as α-fetoprotein (AFP) and micro-RNAs represent useful tools but still have limita
Externí odkaz:
https://doaj.org/article/5a5ac576d61046a1baa3f3f39d5ddbe3
Publikováno v:
Liver Research, Vol 7, Iss 4, Pp 361-364 (2023)
Although direct-acting antivirals (DAAs) have notably increased the sustained virological response (SVR) rates in hepatitis C virus (HCV)-infected adolescent patients, the efficacy and safety for young children under 3 years old remain unclear. Curre
Externí odkaz:
https://doaj.org/article/6c43d2c02ba243b2967b3743565edd83
Publikováno v:
Diagnostics, Vol 14, Iss 19, p 2179 (2024)
Background/Objectives: The Elecsys® HCV Duo immunoassay (Roche Diagnostics International Ltd., Rotkreuz, Switzerland) detects both antibodies to hepatitis C virus (anti-HCV) and HCV core antigen (HCV-Ag) and has shown excellent diagnostic performanc
Externí odkaz:
https://doaj.org/article/41e667f9af7a4f22831c76fdb527fa37
Autor:
Hunter Spencer, Devin Gregoire, Gillian Leichtling, Megan Herink, Andrew Seaman, P. Todd Korthuis, Ryan Cook
Publikováno v:
Viruses, Vol 16, Iss 9, p 1455 (2024)
Hepatitis C (HCV) treatment for people who use drugs (PWUD) decreases injection drug use and injection equipment sharing. We examined changes in injection drug use and injection equipment sharing following HCV treatment in a randomized trial comparin
Externí odkaz:
https://doaj.org/article/6315473fbbf14b1194e2cdd8734da085